Androgenic Alopecia. Androgenic alopecia
Conditions
Interventions
Intervention 1: Intervention group 1: Patients in the first group use Minoxidil solution 2% once a day and Spironolactone (100 mg daily in two doses) for 4 months. Intervention 2: Intervention group 2
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: scalp involvement aged 15-45 years satisfaction to participate in the study ability to follow the patient based on the doctor's diagnosis normal hormonal tests
Exclusion criteria
Exclusion criteria: having an underlying disease history of polycystic ovary syndrome history of treatment in the last two months for the disease contraindications to the use of spironolactone or finasteride such as pregnancy and lactation concomitant use of drugs that may interact with the drugs under study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of alopecia. Timepoint: At the beginning of the study, 2 and 4 months later. Method of measurement: based on Ludwig grade by patient s physician.;Qualitative and quantitative severity of alopecia. Timepoint: At the beginning of the study, 2 and 4 months later. Method of measurement: based on clinical and dermatoscopic images by a blind dermatologist.;The rate of improvement. Timepoint: 2 and 4 months after the beginning of the treatment. Method of measurement: based on patient satisfaction scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfsaneh Sadeghzadeh Bazargan
Iran University of Medical Sciences
Outcome results
None listed